CD44 and gastric cancer: Using real-time quantitative PCR method, we identified three frequently amplified genes from 30 candidate genes, including ERBB4, C-MET and CD44 genes, in 30 pairs of gastric cancer and normal gastric tissues, and further demonstrated that aberrant amplification of these genes significantly affected the clinical outcome in a cohort of clinically well-characterized gastric cancers.